Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Tarcela Gler

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Journal of Global Antimicrobial Resistance|June 12, 2021
Implementation of a multidisciplinary antimicrobial stewardship programme in a Philippine tertiary care hospital: an evaluation by repeated point prevalence surveysGina de Guzman Betito, Ines Pauwels, Ann Versporten, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 1, 2025
Utilizing Whole Genome Sequencing to Investigate a COVID-19 Cluster Among Healthcare Workers in a Tertiary Care Facility in the Philippines: Insights and Implications for Infection Prevention and ControlGina de Guzman Betito, Reed Magleby, Janice C Caoili, et al.
Plos Medicine|April 13, 2019
Lipoarabinomannan in sputum to detect bacterial load and treatment response in patients with pulmonary tuberculosis: Analytic validation and evaluation in two cohortsMasanori Kawasaki, Carmenchu Echiverri, Lawrence Raymond, et al.
Antimicrobial Agents and Chemotherapy|April 11, 2022
Delamanid Added to an Optimized Background Regimen in Children with Multidrug-Resistant Tuberculosis: Results of a Phase I/II Clinical TrialAnthony J Garcia-Prats, Melchior Frias, Louvina van der Laan, et al.
Antimicrobial Agents and Chemotherapy|August 7, 2019
Delamanid Central Nervous System Pharmacokinetics in Tuberculous Meningitis in Rabbits and HumansElizabeth W Tucker, Lisa Pieterse, Matthew D Zimmerman, et al.
Antimicrobial Agents and Chemotherapy|November 5, 2014
Evaluation of pyrosequencing for detecting extensively drug-resistant Mycobacterium tuberculosis among clinical isolates from four high-burden countriesKanchan Ajbani, Shou-Yean Grace Lin, Camilla Rodrigues, et al.
Plos Medicine|November 17, 2011
Rapid diagnosis of tuberculosis with the Xpert MTB/RIF assay in high burden countries: a cost-effectiveness analysisAnna Vassall, Sanne van Kampen, Hojoon Sohn, et al.
Emerging Microbes & Infections|August 8, 2015
Novel katG mutations causing isoniazid resistance in clinical M. tuberculosis isolatesJessica N Torres, Lynthia V Paul, Timothy C Rodwell, et al.
Journal of Clinical Microbiology|December 20, 2013
Predicting extensively drug-resistant Mycobacterium tuberculosis phenotypes with genetic mutationsTimothy C Rodwell, Faramarz Valafar, James Douglas, et al.
The New England Journal of Medicine|June 8, 2012
Delamanid for multidrug-resistant pulmonary tuberculosisMaria Tarcela Gler, Vija Skripconoka, Epifanio Sanchez-Garavito, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Journal of Global Antimicrobial Resistance|June 12, 2021
Implementation of a multidisciplinary antimicrobial stewardship programme in a Philippine tertiary care hospital: an evaluation by repeated point prevalence surveysGina de Guzman Betito, Ines Pauwels, Ann Versporten, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 1, 2025
Utilizing Whole Genome Sequencing to Investigate a COVID-19 Cluster Among Healthcare Workers in a Tertiary Care Facility in the Philippines: Insights and Implications for Infection Prevention and ControlGina de Guzman Betito, Reed Magleby, Janice C Caoili, et al.
Plos Medicine|April 13, 2019
Lipoarabinomannan in sputum to detect bacterial load and treatment response in patients with pulmonary tuberculosis: Analytic validation and evaluation in two cohortsMasanori Kawasaki, Carmenchu Echiverri, Lawrence Raymond, et al.
Antimicrobial Agents and Chemotherapy|April 11, 2022
Delamanid Added to an Optimized Background Regimen in Children with Multidrug-Resistant Tuberculosis: Results of a Phase I/II Clinical TrialAnthony J Garcia-Prats, Melchior Frias, Louvina van der Laan, et al.
Antimicrobial Agents and Chemotherapy|August 7, 2019
Delamanid Central Nervous System Pharmacokinetics in Tuberculous Meningitis in Rabbits and HumansElizabeth W Tucker, Lisa Pieterse, Matthew D Zimmerman, et al.
Antimicrobial Agents and Chemotherapy|November 5, 2014
Evaluation of pyrosequencing for detecting extensively drug-resistant Mycobacterium tuberculosis among clinical isolates from four high-burden countriesKanchan Ajbani, Shou-Yean Grace Lin, Camilla Rodrigues, et al.
Plos Medicine|November 17, 2011
Rapid diagnosis of tuberculosis with the Xpert MTB/RIF assay in high burden countries: a cost-effectiveness analysisAnna Vassall, Sanne van Kampen, Hojoon Sohn, et al.
Emerging Microbes & Infections|August 8, 2015
Novel katG mutations causing isoniazid resistance in clinical M. tuberculosis isolatesJessica N Torres, Lynthia V Paul, Timothy C Rodwell, et al.
Journal of Clinical Microbiology|December 20, 2013
Predicting extensively drug-resistant Mycobacterium tuberculosis phenotypes with genetic mutationsTimothy C Rodwell, Faramarz Valafar, James Douglas, et al.
The New England Journal of Medicine|June 8, 2012
Delamanid for multidrug-resistant pulmonary tuberculosisMaria Tarcela Gler, Vija Skripconoka, Epifanio Sanchez-Garavito, et al.
Pageof 2